Clinical Laboratory

You have to be registered and logged in for purchasing articles.

Abstract	AML with RUNX1::RUNX1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR by XinhongYang, Yingwei Wu, Xiaofeng Yang, Xue Wu, Yingying Chen, Rongjuan Zhang, Zhihua Zhang

	Background: Acute myeloid leukemia (AML) with t(8;21)(q22;q22.1); RUNX1::RUNX1T1 has a relatively favorable prognosis with a high complete remission rate and long disease-free survival. Methods and Results: Here we describe a patient who had AML with t(8;21)(q22;q22.1); RUNX1::RUNX1T1. Cooperating mutations including KRAS and ASXL1, and with other abnormal karyotype del(17) and with a myelomonocytic differentiation. Conclusions: The patient relapsed despite achieving a morphologic complete remission (CR). DOI: 10.7754/Clin.Lab.2023.230923

Abstract